Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Essa Y Baitei

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Endocrinology|March 26, 2008
Genotype-phenotype correlation in a family with primary cortisol resistance: possible modulating effect of the ER22/23EK polymorphismHussein Raef, Essa Y Baitei, Minjing Zou, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2006
Clinical case seminar: metastatic follicular thyroid carcinoma arising from congenital goiter as a result of a novel splice donor site mutation in the thyroglobulin geneAli S Alzahrani, Essa Y Baitei, Minjing Zou, et al.
Neoplasia (New York, N.Y.)|December 25, 2008
Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumorsMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 30, 2008
Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutationAli S Alzahrani, Nojoud Al-Khaldi, Yufei Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2006
Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse modelYufei Shi, Minjing Zou, Katharine Collison, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1Ali S Alzahrani, Minjing Zou, Essa Y Baitei, et al.
Endocrine|May 24, 2011
Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutationsMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
The Journal of Pathology|January 22, 2009
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinomaEssa Y Baitei, Minjing Zou, Futwan Al-Mohanna, et al.
Clinical Endocrinology|January 3, 2014
Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinomaMinjing Zou, Faisal S BinHumaid, Ali S Alzahrani, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2015
IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse modelRanjit S Parhar, Minjing Zou, Futwan A Al-Mohanna, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Endocrinology|March 26, 2008
Genotype-phenotype correlation in a family with primary cortisol resistance: possible modulating effect of the ER22/23EK polymorphismHussein Raef, Essa Y Baitei, Minjing Zou, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2006
Clinical case seminar: metastatic follicular thyroid carcinoma arising from congenital goiter as a result of a novel splice donor site mutation in the thyroglobulin geneAli S Alzahrani, Essa Y Baitei, Minjing Zou, et al.
Neoplasia (New York, N.Y.)|December 25, 2008
Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumorsMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 30, 2008
Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutationAli S Alzahrani, Nojoud Al-Khaldi, Yufei Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2006
Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse modelYufei Shi, Minjing Zou, Katharine Collison, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1Ali S Alzahrani, Minjing Zou, Essa Y Baitei, et al.
Endocrine|May 24, 2011
Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutationsMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
The Journal of Pathology|January 22, 2009
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinomaEssa Y Baitei, Minjing Zou, Futwan Al-Mohanna, et al.
Clinical Endocrinology|January 3, 2014
Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinomaMinjing Zou, Faisal S BinHumaid, Ali S Alzahrani, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2015
IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse modelRanjit S Parhar, Minjing Zou, Futwan A Al-Mohanna, et al.
Pageof 3